The Canadian Chronic Disease Surveillance System (CCDSS) uses linked administrative data sources from every province and territory to estimate the incidence and prevalence of chronic conditions, and, use of health services and health outcomes. Its aim is to foster the collection of surveillance data in a consistent and comparable way across jurisdictions. Patient privacy is protected since only population-level summaries are shared by the provinces and territories. Tracking health conditions through this approach complements other surveillance data sources, such as surveys and registries, and allows for timely reporting to support the planning and evaluation of policies and programs. The Public Health Agency of Canada used provincial and territorial data to create the Pan-Canadian data, available on this website. Provincial and territorial specific data are accessible on the Agency’s Public Health Infobase: https://health-infobase.canada.ca/ccdss/data-tool/

"In Canada, heart disease is the second leading cause of death after cancer, and a leading cause of hospitalization. Ischemic heart disease, the most common form of heart disease, is the first cause of years of life lost (years lost due to premature mortality) and the second leading cause of disability-adjusted life years lost (the number of years lost due to ill-health, disability or early death). "

Distribution of the household population by chronic diseases, by sex and age group.

The Canadian Chronic Disease Indicators (CCDI) provide information on chronic diseases, their determinants, and their risk and protective factors in Canada. Pan-Canadian estimates, time trends and data breakdowns by demographic and socioeconomic variables are provided for each indicator and their specific measures.

Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice(the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada.The journal publishes articles on disease prevention, health promotion and health equity in the areas of chronic diseases, injuries and life course health. Content includes research from fields such as public/community health, epidemiology, biostatistics, the behavioural and social sciences, and health services or economics.

The CCDSS is a collaborative network of provincial and territorial surveillance systems collecting data on all residents across Canada who are eligible for provincial or territorial health insurance. Provincial and territorial health insurance registry records are linked using a unique personal identifier to the corresponding physician billing claims, hospital discharge abstract records, and prescription drug records.

Chronic conditions among seniors aged 65 and older, Canadian Health Survey on Seniors, by age group and sex, Canada (excluding territories) and provinces. This table uses two-year period estimates from the 2019/2020 pooled data. For annual estimates, see table 13-10-0788.

The Canadian Chronic Disease Surveillance System (CCDSS) uses linked administrative data sources from every province and territory to estimate the incidence and prevalence of chronic conditions, and, use of health services and health outcomes. Its aim is to foster the collection of surveillance data in a consistent and comparable way across jurisdictions. Patient privacy is protected since only population-level summaries are shared by the provinces and territories. Tracking health conditions through this approach complements other surveillance data sources, such as surveys and registries, and allows for timely reporting to support the planning and evaluation of policies and programs. The Public Health Agency of Canada used provincial and territorial data to create the Pan-Canadian data, available on this website. Provincial and territorial specific data are accessible on the Agency’s Public Health Infobase: https://health-infobase.canada.ca/ccdss/data-tool/

Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice (the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada. The journal publishes articles on disease prevention, health promotion and health equity in the areas of chronic diseases, injuries and life course health. Content includes research from fields such as public/community health, epidemiology, biostatistics, the behavioural and social sciences, and health services or economics. Special collection on COVID-19 and mental health – Published September 27, 2021

Aging and Chronic Diseases: A Profile of Canadian Seniors. This report was developed before the current pandemic and focuses on the health and chronic disease patterns of Canadian seniors. It provides the data and scientific context we need to make evidence-based decisions to address chronic diseases, some of which increase the risk of severe COVID-19, and other challenges to the health of seniors. Going forward, we will monitor the impacts related to the comorbidity of COVID-19 and chronic diseases and other long-term consequences.

"In Canada, heart disease is the second leading cause of death after cancer, and a leading cause of hospitalization. Ischemic heart disease, the most common form of heart disease, is the first cause of years of life lost (years lost due to premature mortality) and the second leading cause of disability-adjusted life years lost (the number of years lost due to ill-health, disability or early death). "

Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice (the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada. The journal publishes articles on disease prevention, health promotion and health equity in the areas of chronic diseases, injuries and life course health. Content includes research from fields such as public/community health, epidemiology, biostatistics, the behavioural and social sciences, and health services or economics. Special collection on COVID-19 and mental health – Published September 27, 2021

Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice (the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada. The journal publishes articles on disease prevention, health promotion and health equity in the areas of chronic diseases, injuries and life course health. Content includes research from fields such as public/community health, epidemiology, biostatistics, the behavioural and social sciences, and health services or economics.

List of Top Disciplines of Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice sorted by citations.

Snapshot img

Chronic Disease Management Market Size 2025-2029

The chronic disease management market size is forecast to increase by USD 5.66 billion, at a CAGR of 11.2% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing geriatric population and the prevalence of chronic diseases. With an aging population comes a higher incidence of chronic conditions, such as diabetes, cardiovascular diseases, and cancer, necessitating effective management solutions. Technological advancements are playing a pivotal role in this market, enabling remote monitoring, telehealth, and data analytics, which improve patient outcomes and reduce healthcare costs. However, challenges persist in the form of medical data privacy concerns. As the digitalization of health data continues, ensuring its security and confidentiality becomes increasingly important to mitigate potential risks and maintain patient trust. Companies seeking to capitalize on market opportunities must prioritize innovation, data security, and regulatory compliance to meet the evolving needs of patients and healthcare providers.

What will be the Size of the Chronic Disease Management Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free SampleThe market continues to evolve, driven by advancements in technology and shifting healthcare priorities. Integral components of this dynamic landscape include machine learning algorithms, interoperability standards, medication adherence tracking, healthcare payers, data security protocols, risk stratification models, and personalized treatment plans. These elements are seamlessly integrated into various sectors, such as diabetes management tools, data analytics dashboards, virtual care consultations, population health management, remote patient monitoring, lifestyle modification programs, telemedicine platforms, mobile health applications, health coaching services, respiratory disease management, predictive modeling, pain management solutions, remote therapeutic monitoring, clinical trials management, patient engagement tools, healthcare IoT devices, AI-powered diagnostics, mental health platforms, behavioral interventions, wearable sensors, oncology care management, and cardiovascular disease management. The ongoing unfolding of market activities reveals a focus on improving patient outcomes through innovative solutions. For instance, machine learning algorithms are employed to analyze vast amounts of data, enabling early detection and intervention. Interoperability standards ensure seamless data exchange between different systems, enhancing care coordination. Medication adherence tracking helps manage chronic conditions more effectively, reducing hospitalizations and improving patient satisfaction. Healthcare payers are increasingly adopting value-based care models, which incentivize providers to deliver high-quality care while managing costs. Data security protocols are strengthened to protect sensitive patient information. Risk stratification models help identify high-risk patients, allowing for targeted interventions and personalized treatment plans. Pharmacovigilance systems monitor drug safety, ensuring patient safety and regulatory compliance. The integration of technology in chronic disease management is transforming the industry, with telemedicine platforms and virtual care consultations enabling remote access to care. Remote patient monitoring allows for continuous monitoring of vital signs, while wearable sensors provide real-time data. AI-powered diagnostics enable faster and more accurate diagnoses. Mental health platforms and behavioral interventions address the growing need for holistic care. In conclusion, the market is characterized by continuous evolution, driven by technological advancements and shifting healthcare priorities. The integration of machine learning algorithms, interoperability standards, medication adherence tracking, healthcare payers, data security protocols, risk stratification models, and personalized treatment plans is transforming the industry, improving patient outcomes and enhancing care coordination. This dynamic landscape is shaping the future of chronic disease management, with a focus on innovation, efficiency, and patient-centered care.

How is this Chronic Disease Management Industry segmented?

The chronic disease management industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. TypeSolutionsServicesEnd-userHealthcare providersHealthcare payersDisease TypeCardiovascular diseasesDiabetesChronic obstructive pulmonary disordersArthritisOthersGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalyUKAPACChinaI

Chronic conditions among seniors aged 65 and older, Canadian Health Survey on Seniors, by age group and sex, Canada (excluding territories) and provinces.

Distribution of sociodemographic and health behaviours of respondents with arthritis, Survey on Living with Chronic Diseases in Canada–Arthritis Component, 2009.

List of Top Schools of Chronic Diseases in Canada sorted by citations.

: Ischemic Heart Disease prevalence data is from the Canadian Chronic Disease Surveillance System (CCDSS). Ischemic heart disease crude prevalence in Nova Scotia. Includes the following data fields: Management Zone, Sex, Age Group, Population, Ischemic Heart disease Count, Crude

Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice (the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada.The journal publishes articles on disease prevention, health promotion and health equity in the areas of chronic diseases, injuries and life course health. Content includes research from fields such as public/community health, epidemiology, biostatistics, the behavioural and social sciences, and health services or economics.